- Exchange: ASE
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Novogen Ltd+ Add to Watchlist
NRT:AU0.2800 AUD 0.00000.00%
As of 02:10:43 ET on 05/05/2015.
Company Profile for Novogen Ltd (NRT)
Novogen Limited is a drug discovery company. The Company owns two proprietary drug technology platforms which include super-benzopyrans and anti-tropomyosins that target broad therapeutic potential across the fields of cancer, musculodegenerative diseases, neurodegenerative diseases, regenerative medicine, lysosomal storage diseases, and autoimmune diseases.
Key Executives for Novogen Ltd (NRT)
|Graham Edmund KellyChairman/CEO||David BrownChief Scientific Officer|
|Cristyn HumphreysCOO:Administration & Finance||W Andrew HeatonVP:Drug Discovery|
|Justine StehnDir:ATM Program||Stephen PalmerDir:Degenerative Disease Program|
|Lionel MateoSecretary||Kimberley LilischkisManager:Clinical & Regulatory Affairs|